GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: Association hypothesis for an uncommon genetic variant

Sara Piacentini, Renato Polimanti, Rosanna Squitti, Stefania Mariani, Simone Migliore, Fabrizio Vernieri, Paolo Maria Rossini, Dario Manfellotto, Maria Fuciarelli

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Glutathione S-transferases are multifunctional enzymes involved in cellular detoxification. A genetic linkage was found between Alzheimer's Disease (AD) and the chromosome 10q, where the GSTO1 and GSTO2 genes are located, leading to the hypothesis that GST Omega class (GSTO) genes may be an AD risk factor. Since it is still controversial, we decided to explore GSTO polymorphisms in Italian cohorts. We analyzed 119 AD patients and 114 healthy controls for the GSTO gene polymorphisms. In particular we investigated two common polymorphisms (GSTO1*A140D, GSTO2*N142D) and two uncommon variants (GSTO1*E155del, GSTO1*E208K) to find loci associated with AD risk. Detection of GSTO1*A140D and GSTO2*N142D was performed by PCR-RFLP, while GSTO1*E155del and GSTO1*E208K were detected using confronting two-pair primer and allele specific PCR, respectively. While GSTO1*A140D, GSTO1*E208K and GSTO2*N142D polymorphisms did not show significant outcomes, the GSTO1*E155del polymorphism is associated with AD [P= 0.003; adjusted OR = 3.70 (1.57-8.75)]. Our results suggest that GSTO1-1 plays a role in AD since the GSTO1*del155 variant is involved in changes in GSTO1-1 activities decreasing in enzyme stability. Specifically, three hypotheses may explain the role of GSTO1-1 in the pathophysiology of AD: the antioxidant activity of GSTO1-1 may protect brain tissue against oxidative stress; GSTO1-1 activity regulate interleukin-1β activation and its genetic variation may act to modulate inflammation in AD; GSTO1-1 is involved in the arsenic biotransformation pathway and gene polymorphisms may be implicated in the modulation of arsenic neurotoxicity. In conclusion, we hypothesized that GSTO1*E155del is an uncommon genetic variant associated with AD risk.

Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalNeuroscience Letters
Volume506
Issue number2
DOIs
Publication statusPublished - Jan 11 2012

Fingerprint

Alzheimer Disease
Arsenic
Genes
Multifunctional Enzymes
Enzyme Stability
Polymerase Chain Reaction
Genetic Linkage
Biotransformation
Glutathione Transferase
Interleukin-1
Restriction Fragment Length Polymorphisms
Oxidative Stress
Antioxidants
Chromosomes
Alleles
Inflammation
Brain

Keywords

  • Glutatione S-transferases
  • GST Omega class
  • Italian population
  • Late-onset Alzheimer's disease
  • Uncommon genetic variants

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease : Association hypothesis for an uncommon genetic variant. / Piacentini, Sara; Polimanti, Renato; Squitti, Rosanna; Mariani, Stefania; Migliore, Simone; Vernieri, Fabrizio; Rossini, Paolo Maria; Manfellotto, Dario; Fuciarelli, Maria.

In: Neuroscience Letters, Vol. 506, No. 2, 11.01.2012, p. 203-207.

Research output: Contribution to journalArticle

Piacentini, S, Polimanti, R, Squitti, R, Mariani, S, Migliore, S, Vernieri, F, Rossini, PM, Manfellotto, D & Fuciarelli, M 2012, 'GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: Association hypothesis for an uncommon genetic variant', Neuroscience Letters, vol. 506, no. 2, pp. 203-207. https://doi.org/10.1016/j.neulet.2011.11.005
Piacentini, Sara ; Polimanti, Renato ; Squitti, Rosanna ; Mariani, Stefania ; Migliore, Simone ; Vernieri, Fabrizio ; Rossini, Paolo Maria ; Manfellotto, Dario ; Fuciarelli, Maria. / GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease : Association hypothesis for an uncommon genetic variant. In: Neuroscience Letters. 2012 ; Vol. 506, No. 2. pp. 203-207.
@article{2fdfa775739f4f51baed7301af9e4d23,
title = "GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: Association hypothesis for an uncommon genetic variant",
abstract = "Glutathione S-transferases are multifunctional enzymes involved in cellular detoxification. A genetic linkage was found between Alzheimer's Disease (AD) and the chromosome 10q, where the GSTO1 and GSTO2 genes are located, leading to the hypothesis that GST Omega class (GSTO) genes may be an AD risk factor. Since it is still controversial, we decided to explore GSTO polymorphisms in Italian cohorts. We analyzed 119 AD patients and 114 healthy controls for the GSTO gene polymorphisms. In particular we investigated two common polymorphisms (GSTO1*A140D, GSTO2*N142D) and two uncommon variants (GSTO1*E155del, GSTO1*E208K) to find loci associated with AD risk. Detection of GSTO1*A140D and GSTO2*N142D was performed by PCR-RFLP, while GSTO1*E155del and GSTO1*E208K were detected using confronting two-pair primer and allele specific PCR, respectively. While GSTO1*A140D, GSTO1*E208K and GSTO2*N142D polymorphisms did not show significant outcomes, the GSTO1*E155del polymorphism is associated with AD [P= 0.003; adjusted OR = 3.70 (1.57-8.75)]. Our results suggest that GSTO1-1 plays a role in AD since the GSTO1*del155 variant is involved in changes in GSTO1-1 activities decreasing in enzyme stability. Specifically, three hypotheses may explain the role of GSTO1-1 in the pathophysiology of AD: the antioxidant activity of GSTO1-1 may protect brain tissue against oxidative stress; GSTO1-1 activity regulate interleukin-1β activation and its genetic variation may act to modulate inflammation in AD; GSTO1-1 is involved in the arsenic biotransformation pathway and gene polymorphisms may be implicated in the modulation of arsenic neurotoxicity. In conclusion, we hypothesized that GSTO1*E155del is an uncommon genetic variant associated with AD risk.",
keywords = "Glutatione S-transferases, GST Omega class, Italian population, Late-onset Alzheimer's disease, Uncommon genetic variants",
author = "Sara Piacentini and Renato Polimanti and Rosanna Squitti and Stefania Mariani and Simone Migliore and Fabrizio Vernieri and Rossini, {Paolo Maria} and Dario Manfellotto and Maria Fuciarelli",
year = "2012",
month = "1",
day = "11",
doi = "10.1016/j.neulet.2011.11.005",
language = "English",
volume = "506",
pages = "203--207",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease

T2 - Association hypothesis for an uncommon genetic variant

AU - Piacentini, Sara

AU - Polimanti, Renato

AU - Squitti, Rosanna

AU - Mariani, Stefania

AU - Migliore, Simone

AU - Vernieri, Fabrizio

AU - Rossini, Paolo Maria

AU - Manfellotto, Dario

AU - Fuciarelli, Maria

PY - 2012/1/11

Y1 - 2012/1/11

N2 - Glutathione S-transferases are multifunctional enzymes involved in cellular detoxification. A genetic linkage was found between Alzheimer's Disease (AD) and the chromosome 10q, where the GSTO1 and GSTO2 genes are located, leading to the hypothesis that GST Omega class (GSTO) genes may be an AD risk factor. Since it is still controversial, we decided to explore GSTO polymorphisms in Italian cohorts. We analyzed 119 AD patients and 114 healthy controls for the GSTO gene polymorphisms. In particular we investigated two common polymorphisms (GSTO1*A140D, GSTO2*N142D) and two uncommon variants (GSTO1*E155del, GSTO1*E208K) to find loci associated with AD risk. Detection of GSTO1*A140D and GSTO2*N142D was performed by PCR-RFLP, while GSTO1*E155del and GSTO1*E208K were detected using confronting two-pair primer and allele specific PCR, respectively. While GSTO1*A140D, GSTO1*E208K and GSTO2*N142D polymorphisms did not show significant outcomes, the GSTO1*E155del polymorphism is associated with AD [P= 0.003; adjusted OR = 3.70 (1.57-8.75)]. Our results suggest that GSTO1-1 plays a role in AD since the GSTO1*del155 variant is involved in changes in GSTO1-1 activities decreasing in enzyme stability. Specifically, three hypotheses may explain the role of GSTO1-1 in the pathophysiology of AD: the antioxidant activity of GSTO1-1 may protect brain tissue against oxidative stress; GSTO1-1 activity regulate interleukin-1β activation and its genetic variation may act to modulate inflammation in AD; GSTO1-1 is involved in the arsenic biotransformation pathway and gene polymorphisms may be implicated in the modulation of arsenic neurotoxicity. In conclusion, we hypothesized that GSTO1*E155del is an uncommon genetic variant associated with AD risk.

AB - Glutathione S-transferases are multifunctional enzymes involved in cellular detoxification. A genetic linkage was found between Alzheimer's Disease (AD) and the chromosome 10q, where the GSTO1 and GSTO2 genes are located, leading to the hypothesis that GST Omega class (GSTO) genes may be an AD risk factor. Since it is still controversial, we decided to explore GSTO polymorphisms in Italian cohorts. We analyzed 119 AD patients and 114 healthy controls for the GSTO gene polymorphisms. In particular we investigated two common polymorphisms (GSTO1*A140D, GSTO2*N142D) and two uncommon variants (GSTO1*E155del, GSTO1*E208K) to find loci associated with AD risk. Detection of GSTO1*A140D and GSTO2*N142D was performed by PCR-RFLP, while GSTO1*E155del and GSTO1*E208K were detected using confronting two-pair primer and allele specific PCR, respectively. While GSTO1*A140D, GSTO1*E208K and GSTO2*N142D polymorphisms did not show significant outcomes, the GSTO1*E155del polymorphism is associated with AD [P= 0.003; adjusted OR = 3.70 (1.57-8.75)]. Our results suggest that GSTO1-1 plays a role in AD since the GSTO1*del155 variant is involved in changes in GSTO1-1 activities decreasing in enzyme stability. Specifically, three hypotheses may explain the role of GSTO1-1 in the pathophysiology of AD: the antioxidant activity of GSTO1-1 may protect brain tissue against oxidative stress; GSTO1-1 activity regulate interleukin-1β activation and its genetic variation may act to modulate inflammation in AD; GSTO1-1 is involved in the arsenic biotransformation pathway and gene polymorphisms may be implicated in the modulation of arsenic neurotoxicity. In conclusion, we hypothesized that GSTO1*E155del is an uncommon genetic variant associated with AD risk.

KW - Glutatione S-transferases

KW - GST Omega class

KW - Italian population

KW - Late-onset Alzheimer's disease

KW - Uncommon genetic variants

UR - http://www.scopus.com/inward/record.url?scp=84655166511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84655166511&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2011.11.005

DO - 10.1016/j.neulet.2011.11.005

M3 - Article

C2 - 22100662

AN - SCOPUS:84655166511

VL - 506

SP - 203

EP - 207

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -